期刊
CURRENT HEMATOLOGIC MALIGNANCY REPORTS
卷 7, 期 3, 页码 228-234出版社
CURRENT MEDICINE GROUP
DOI: 10.1007/s11899-012-0125-2
关键词
Hodgkin's lymphoma; HIV; AIDS; PET-scan; EBV; CD4 cell count; HAART; Hematopoietic growth factors
Hodgkin lymphoma (HL) is one of the most common types of non-AIDS-defining tumors in the HIV-infected. Its incidence however seems to have increased under highly active anti-retroviral therapy (HAART). HIV-HL is a different entity from HL in HIV-negative subjects with a poorer prognosis that is associated with tumor-subtype, EBV-infection, and B symptoms. Despite the aggressive nature of the disease, clinical outcome has improved with combination therapies including appropriately timed antiretroviral strategies and the quality of supportive care-notably the use of hematopoietic growth factors. More intensive chemotherapy regimens with or without autologous stem cell transplantation appear to improve survival. Functional imaging such as positron emission tomography and computed tomography (FDG-PET) may help guide treatment strategy and minimize long-term toxicity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据